scout
|Videos|July 20, 2016

JAVELIN Trial Design and Safety Results in Gastric Cancer

Hendrik-Tobias Arkenau, MD, PhD, founding medical director, executive medical director, Sarah Cannon Research Institute UK, gives an overview of the JAVELIN trial in gastric cancer. He also discusses the safety profile of avelumab.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME